Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1945–1968 of 2,293 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiac Ischemia Clear all

Conditions: Coronary Artery Disease
Interventions: Peer Mentor, Transcendental Meditation; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Ischemic Heart Disease, Microvascular Coronary Artery Disease, Diastolic Dysfunction, Heart Failure With Preserved Ejection Fraction
Interventions: Echocardiography, Coronary flow reserve and index of microcirculatory dysfunction; Diagnostic Test
Lead sponsor: Samsung Medical Center; Other
Eligibility: Not listed
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Acute Coronary Syndrome, Chest Pain
Interventions: Serial Electrocardiograms; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years and older
Enrollment: 382 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Heart Failure, Cardiogenic Shock
Interventions: 1:1 Randomization to receive milrinone; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Coronary Artery Disease, Chronic Kidney Disease, Hypovitaminosis D, Secondary Hyperparathyroidism
Interventions: paricalcitol, placebo; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Myocardial Infarction
Interventions: eptifibitide; Drug
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Coronary Artery Disease
Interventions: Cardiac CT, Invasive Coronary Angiography; Procedure
Lead sponsor: MDDX LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 1,631 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Myocardial Ischemia, Congestive Heart Failure, Cardiovascular Disease
Interventions: Intramyocardial injection of autologous CD34-positive cells (stem cells); Biological
Lead sponsor: Losordo, Douglas, M.D.; Individual
Eligibility: 21 Years to 80 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: HIV, Coronary Artery Disease
Interventions: metformin extended release; Drug
Lead sponsor: University of Hawaii; Other
Eligibility: 45 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Acute Coronary Syndrome, Fear Anxiety, Physical Inactivity
Interventions: Reducing Exercise Sensitivity with Exposure Training; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Ischemic Cardiomyopathy, Chronic Ischemic Cardiomyopathy
Interventions: Endomyocardial injections of allogeneic Human CSps, Endomyocardial injections of vehicle only.; Biological
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Dyslipidemias, Coronary Heart Disease, Combined (Atherogenic) Dyslipidemia, Mixed Dyslipidemia
Interventions: ABT-335, placebo, atorvastatin, ezetimibe; Drug
Lead sponsor: Abbott; Industry
Eligibility: 18 Years and older
Enrollment: 543 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 118
States / cities: Birmingham, Alabama • Columbiana, Alabama • Hueytown, Alabama + 107 more

Conditions: Normal Healthy Volunteers Without Chronic Medical Conditions, Coronary Artery Disease, Cardiac Risk Factors, Myocardial Infarction
Interventions: Slow Infusion of Rubidium-82; Drug
Lead sponsor: Ochsner Health System; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Myocardial Infarction
Interventions: AO Therapy (aqueous oxygen); Device
Lead sponsor: TherOx; Industry
Eligibility: 18 Years and older
Enrollment: 317 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Bryn Mawr, Pennsylvania

Conditions: Cardiovascular Disease
Interventions: Not listed
Lead sponsor: Tufts University; Other
Eligibility: 65 Years and older · Female only
Enrollment: 2,448 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease
Interventions: Apadenoson SPECT-MPI, Adenosine SPECT-MPI; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 45
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Beverly Hills, California + 37 more

Conditions: Coronary Artery Disease, Hypertension, Hyperlipidemias, Peripheral Vascular Diseases, Cerebral Arterial Diseases
Interventions: Goodbelly, Placebo; Dietary Supplement
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 21 Years to 89 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Wauwatosa, Wisconsin

Conditions: Cardiomyopathy, Hypertrophic, Coronary Disease, Healthy, Myocardial Ischemia, Syndrome X
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1995 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiogenic Shock, Mitral Regurgitation
Interventions: Transcatheter edge-to-edge repair, Medical therapy; Device · Other
Lead sponsor: Ottawa Heart Institute Research Corporation; Other
Eligibility: 18 Years and older
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Coronary Artery Disease
Interventions: Apadenoson SPECT-MPI, Adenosine SPECT-MPI; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 863 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 103
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 87 more

Conditions: Mitral Valve Insufficiency, Coronary Artery Disease
Interventions: Mitral Valve Repair, CABG; Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 19
States / cities: Los Angeles, California • Atlanta, Georgia • Marietta, Georgia + 16 more

Conditions: Coronary Artery Disease
Interventions: [3H] BMS747158; Drug
Lead sponsor: Lantheus Medical Imaging; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Coronary Artery Disease
Interventions: AI-700; Drug
Lead sponsor: Acusphere; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Watertown, Massachusetts

Conditions: Coronary Artery Disease, Chronic Total Occlusion of Coronary Artery, Percutaneous Coronary Intervention
Interventions: Robotic CTO PCI, Conventional (Manual) CTO PCI; Device · Procedure
Lead sponsor: Siemens Healthineers Endovascular Robotics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 74 participants
Timeline: 2019 – 2021
U.S. locations: 3
States / cities: Kansas City, Missouri • York, Pennsylvania • Seattle, Washington

Search by objective public record fields.

Peer Mentored Approaches For Men And Women With Coronary Artery Disease ("4Steps")

Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function

Are Serial Electrocardiograms Additive to SeriAl Second-generations Troponins in Predicting Acute CoronAry Syndromes in PatienTs With Undifferentiated cHest Pain

Cardiac Power Output in Cardiogenic Shock Patients

Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease

Eptifibatide and ST Segment Resolution Following Primary PCI

Coronary Computed Tomographic Angiography for Selective Cardiac Catheterization

Stem Cell Study for Subjects With Congestive Heart Failure

Metformin for HIV Inflammation

The Reducing Exercise Sensitivity With Exposure Training (RESET) Study

REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts

Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

3D PET Myocardial Blood Flow and Rb82 Infusion Profiles

Acute Myocardial Infarction With HyperOxemic Therapy II (AMIHOT II)

Predictive Value of Coronary Heart Disease (CHD) Biomarkers for CHD Death

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

Acute Probiotic Supplementation and Endothelial Function

Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers

Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

Comparing the Effectiveness of a Mitral Valve Repair Procedure in Combination With Coronary Artery Bypass Grafting (CABG) Versus CABG Alone in People With Moderate Ischemic Mitral Regurgitation

Study of [3H] BMS747158 in Healthy Male Subjects

Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study

Cardiac Cath Lab Staff Radiation Exposure